Introduction | 31 1 References 1. Incidentie hoofd-halskanker [Internet]. [cited 2021 Aug 12]. Available from: https://iknl.nl/kankersoorten/ hoofd-halskanker/registratie/incidentie 2. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013 Mar 1;132(5):1133–45. 3. Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncology. 2015 Aug 1;51(8):727–30. 4. Sterfte hoofd-halskanker [Internet]. [cited 2024 Mar 15]. Available from: https://iknl.nl/kankersoorten/ hoofd-halskanker/registratie/sterfte 5. Huang SH, O’Sullivan B. Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol. 2017 Jul;18(7):40. 6. Overleving hoofd-halskanker [Internet]. [cited 2024 Mar 15]. Available from: https://iknl.nl/kankersoorten/ hoofd-halskanker/registratie/overleving 7. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. The New England journal of medicine. 2010 Jul 1;363(1):2435. 8. Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancersmajor changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians. 2017 Mar;67(2):122–37. 9. O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016 Apr;17(4):440–51. 10. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. The LancetOncology. 2014 Nov;15(12):1319–31. 11. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? Journal of the National Comprehensive Cancer Network : JNCCN. 2011 Jun 1;9(6):665–73. 12. Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACHNC Group. Radiother Oncol. 2021 Mar;156:281–93. 13. Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, Rich JT, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011 Dec;33(12):1683–94. 14. Yeh DH, Tam S, Fung K, MacNeil SD, Yoo J, Winquist E, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma – A systematic review of the literature. European Journal of Surgical Oncology (EJSO). 2015;41(12):1603–14. 15. Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, et al. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. JCO. 2022 Jan 7;JCO.21.01961. 16. Poupore NS, Chen T, Nguyen SA, Nathan CAO, Newman JG. Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma of the Tonsil versus Base of Tongue: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022 Aug 8;14(15):3837. 17. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for OtoRhino-Laryngology - Head and Neck Surgery. 2015 Feb;272(2):463–71.
RkJQdWJsaXNoZXIy MTk4NDMw